Becton Dickinson's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Becton Dickinson in the third quarter 2026?
Becton Dickinson And Company achieved a return on average equity (ROE) of 3.79 % in its third quarter 2026, which is below Becton Dickinson's average return on equity, which stands at 14.74%.

ROE fell compared to the second quarter 2026, despite the net income growth of % from the second quarter 2026.

Within the Medical Equipment & Supplies industry 54 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 1980 to 2012.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) III. Quarter	(Mar 31 2026) II. Quarter	(Dec 31 2025) I. Quarter	(Sep 30 2025) IV. Quarter	(Jun 30 2025) III. Quarter
Y / Y Equity Change	-4.15 %	-4.39 %	-1.93 %	-1.93 %	-
Y / Y Net Income Change	-34.32 %	-	26.07 %	23.25 %	17.86 %
Net Income (TTM) in Millions	941	1,138	1,757	1,678	1,585
Return On Equity (TTM)	3.79 %	4.53 %	6.92 %	6.58 %	6.19 %
BDX's Total Ranking	# 2012	# 1980	# 1461	# 1569	# 1606
Equity (TTM) in Millions	24,416	24,133	25,390	25,390	25,472
Seq. Equity Change	1.17 %	-4.95 %	0 %	-0.32 %	0.92 %
Seq. Net Income Change	-	-	-22.52 %	-14.11 %	86.36 %

Back to BDX Management Effectiveness >> BDX's 5 Years Annual ROE >> Compare BDX ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 55
Sector	# 171
Overall	# 2012

Return On Equity Statistics
High	Average	Low
30.29 %	14.74 %	0.31 %
(March 31, 2011)		(Mar 31 2018)

BDX Annual Return On Equity	(Sep 30 2025) 2025	(Sep 30 2024) 2024	(Sep 30 2023) 2023	(Sep 30 2022) 2022	(Sep 30 2021) 2021
Total Equity in Millions	25,390	25,890	25,796	25,282	23,677
Y / Y Equity Change	-1.93 %	0.36 %	2.03 %	6.78 %	-0.37 %
Net Income in Millions	1,678	1,705	1,484	1,779	2,092
Y / Y Net Income Change	-1.58 %	14.89 %	-16.58 %	-14.96 %	139.36 %
Return On Equity	6.61 %	6.59 %	5.75 %	7.04 %	8.84 %

Back to BDX Management Effectiveness >> BDX's 5 Years Annual ROE >> Compare BDX ROE to its Competitors

Annual Roe Comment

Despite deterioration in net income, company improved ROE to in 2025, company improved ROE to 6.61 % compared to the prior year.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
BDX's' Return on Equity at Yahoo Finance
BDX's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for BDX's Competitors
Subscribers only: Roe for Becton Dickinson's Suppliers
Subscribers only: Return On Equity for BDX's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector	ROE
The Pennant Group Inc	10.18 %
Amphastar Pharmaceuticals Inc	10.11 %
Align Technology inc	10.09 %
Ardent Health Inc	9.92 %
Edwards Lifesciences Corporation	9.65 %
Addus Homecare Corp	9.57 %
IMPACT BIOMEDICAL INC.	9.56 %
Teva Pharmaceutical Industries Limited	9.11 %
Merit Medical Systems Inc	9.07 %
Bio techne Corp	9.01 %
Utah Medical Products Inc	8.74 %
Vaso Corporation	8.65 %
Veracyte Inc	8.64 %
Corcept Therapeutics Inc	8.27 %
Integer Holdings Corporation	7.43 %
Pacific Health Care Organization Inc	7.42 %
Vericel Corporation	6.91 %
The Cooper Companies Inc	6.90 %
Siga Technologies Inc	6.74 %
Merck and Co Inc	6.59 %
Zimmer Biomet Holdings Inc	6.36 %
National Vision Holdings Inc	5.71 %
Conmed Corporation	5.51 %
Pfizer Inc	4.91 %
Privia Health Group Inc	4.23 %
Becton Dickinson And Company	3.79 %
Alkermes Plc	3.72 %
Lifemd Inc	3.47 %
Lifestance Health Group Inc	3.39 %
Revvity Inc	3.27 %

Date modified: 2026-09-08T15:11:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.